© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Erythromycin came onto the medical scene in the 1950s, discovered from a strain of Streptomyces erythreus. Back then, antibiotics offered a fighting chance against infections that once spelled doom for many. Erythromycin’s original salt forms sometimes triggered stomach cramps and irritation. The search for a gentler formulation led researchers to build upon erythromycin’s structure, and the ethylsuccinate ester came about as a solution. Changing its chemical form reduced acid sensitivity and improved absorption, especially for kids and patients who struggled with stomach side effects. Pharmacies started stocking the ethylsuccinate version as physicians began prescribing it for respiratory, skin, and soft tissue infections, opening the door for broader use and better treatment outcomes.
Erythromycin Ethylsuccinate belongs to the macrolide antibiotic family. Medical staff reach for it to treat illnesses like strep throat, pneumonia, bronchitis, and ear infections. Unlike early erythromycin tablets, this ester form stays stable in stomach acid, letting more of the drug reach the infection. Medicines come as scored white tablets, chewables, and suspensions—a nod to its use in pediatrics. Hospitals value its flexibility: doctors can give the same medication to adults and kids, swapping out the form that fits best.
As a crystalline powder, erythromycin ethylsuccinate shows off a faint, distinctive antibiotic scent. It skips dissolving in water, preferring organic routes like methanol or ethanol, making it handle differently during production. With a melting point ranging around 118–120°C, stability holds firm under typical storage. Chemists like its molecular formula—C43H75NO16—and molar mass near 862 g/mol. These concrete details guide quality assurance in the lab and keep production on track, minimizing surprises batch after batch.
Each batch of erythromycin ethylsuccinate carries a certificate detailing its purity, appearance, and assay results. Manufacturers test not just for the main ingredient, but also for unwanted byproducts, moisture, and microbial counts. Labeling follows strict laws in countries like the US and those in the EU. Information must list active content per tablet or mL, recommended storage (usually, “store below 25°C” and away from moisture), and possible side effects. Box inserts remind health workers about proper dosing for children and adults, as well as the risk of allergic reactions or liver issues. Pharmacists rely on this transparent labeling: mistakes or ambiguity mean health hazards.
Making erythromycin ethylsuccinate involves an esterification process. Chemists react erythromycin base with ethylsuccinic anhydride in the presence of an organic solvent and a basic catalyst. This controlled environment avoids excess heat and moisture, both of which break down the molecule. Once the reaction finishes, technicians extract and purify the new compound using solvents, filtration, and crystallization. Each step makes a difference: too much heat, and the product degrades; not enough purification, and impurities linger. Factories monitor these variables to keep output high and quality reliable.
Transforming erythromycin into its ethylsuccinate form changes the antibiotic only where needed—at the hydroxy group—leaving the macrolide ring, which does the infection-fighting work, untouched. Other chemical tweaks include turning erythromycin into stearate or lactobionate salts. These variants aim to tackle different solubility or stability demands in the clinic. Drug researchers keep treating this core structure as a sandbox: by modifying side chains or adding functional groups, they hope to dodge resistance, improve taste, and reduce adverse reactions. It’s a fine balance between tweaking enough for better results and not so much that safety falters.
Erythromycin ethylsuccinate sometimes appears on pharmacy shelves under trade names like EES, EryPed, and Erythroped. These alternatives help clinics keep organizations straight: the same molecule, just dressed in a different label for any given market. Lists of international synonyms let doctors cross-check if their patients come from abroad or show up with prescription documents in another language. This pragmatic approach cuts down mistakes and ensures people get the medicine they actually need—not a lookalike or a different antibiotic entirely.
Pharmaceutical-grade erythromycin ethylsuccinate sticks to guidelines from groups like the US Pharmacopeia and the European Pharmacopoeia. Plants producing it limit worker contact: personal protective gear, regular air monitoring, and careful handling of solvents stay non-negotiable. Spills or improper storage threaten both batch purity and worker safety. On the distribution side, temperature and humidity tracking in warehouses and during transport guard against loss of potency. Health care providers coach patients about possible allergic reactions, especially those who once reacted to other antibiotics. Clear communication, good training, and enforced safety checks build trust throughout the supply chain.
Hospitals turn to erythromycin ethylsuccinate when tackling bacterial infections caused by gram-positive and some gram-negative bacteria. Its value shines through for treating kids who can’t handle injections or taste bitterness in other tablets. Doctors prescribe it for respiratory tract infections, whooping cough, acne, skin rashes, and certain chlamydial infections. Rural clinics like its shelf stability and flexible dosing, while urban hospitals appreciate its use when allergies or resistance keep penicillins or cephalosporins off the table. Over the decades, it has rescued patients from complications tied to untreated infections, showing a real-world impact that stretches from city centers to remote villages.
Research continues apace as scientists try to outmaneuver antibiotic resistance. Labs across the globe test erythromycin analogs and modifications, hoping to stretch the medicine’s reach. Recent research throws light on nanotechnology’s role: by loading the drug into nanoparticles, absorption improves, and side effects drop. Geneticists map out how bacteria gain resistance to old formulations, offering a blueprint for next-generation improvements. Academic teams also probe new delivery formats, eyeing oral thin films, extended-release pills, and flavor adjustments. Grants from government agencies keep labs funded for trials, toxicology screens, and follow-up studies to make sure changes don’t backfire.
Safety studies on erythromycin ethylsuccinate run deep. Early screens in animals gave researchers clues on safe dosing before the medicine ever reached a pharmacy shelf. Scientists measure toxicity by looking at how the drug spreads in the body, how organs clear it, and whether it irritates tissues. Adverse reactions—liver enzyme spikes, allergic rashes, and stomach cramps—get tracked in thousands of patients. Long-term studies probe whether kids develop teeth discoloration or rare arrhythmias, helping set clear prescribing rules. Regulatory bodies pore over this data before allowing a new use or formulation onto the market. This relentless, ongoing research sets a high bar, keeping patient safety as the center of every update and label revision.
Antibiotic resistance stands as one of medicine’s biggest challenges. Erythromycin ethylsuccinate’s basic structure remains solid, but tomorrow’s strategies build on new chemical tweaks, improved packaging, and smarter education for prescribing. Drug developers invest in crystal engineering, striving for versions that last longer on the shelf or dissolve faster in emergency care. Global health advocates look for ways to expand access in underserved regions, cutting out counterfeit pills and boosting quality controls. Medical educators focus on coaching prescribers to avoid unnecessary use, training them to reserve antibiotics for true infections. With every update to the molecule and every new safety study, this well-traveled antibiotic stays in the fight—a testament to both chemistry and community care working hand in hand.
Erythromycin Ethylsuccinate treats a range of infections caused by bacteria. It steps into the spotlight most often when someone can’t use penicillin because of an allergy or bad side effects. Doctors reach for it to handle strep throat, ear infections, pneumonia, and sinus infections. Kids with whooping cough or pink eye might also get this medicine. Skin infections rank high on the list too—think impetigo or infected scrapes after a playground tumble.
The real reason Erythromycin Ethylsuccinate stands out comes down to its delivery. Tablets and liquid forms help doctors treat kids and adults, even in situations where swallowing a pill doesn’t work well. I’ve seen patients in my own family take this antibiotic in liquid form after wisdom tooth surgery. Anyone with a tough time swallowing standard pills can get some relief knowing this option exists.
Resistance keeps growing because antibiotics sometimes wind up prescribed for the wrong reasons, or people don’t finish the whole bottle. Erythromycin belongs to the macrolide family, a group that still handles many bacterial infections despite rising drug resistance. From my own experience with respiratory bugs that didn’t clear up on their own, getting on the right antibiotic based on history and lab work made a huge difference—not just for quick recovery, but also for steering clear of long-term complications.
Bacteria grow by making protein. Erythromycin Ethylsuccinate stops them from building that protein, so they can’t multiply. Without new bacteria building up, the immune system gets a better shot at fighting off what’s left. This has been shown in studies looking at both mild and stubborn infections. That’s important with tough bugs like Mycoplasma pneumoniae or certain strains of strep, which sometimes brush aside other antibiotics.
Doctors don’t hand out this prescription just for a sniffle. Most colds and flus come from viruses, and no antibiotic will touch those. But if a test comes back positive for a bacterial infection—like strep throat or bacterial pneumonia—using this antibiotic keeps the risks low for someone who can’t take penicillin. Some folks, including children, pregnant women, or folks with kidney problems, need extra safety. Erythromycin Ethylsuccinate moves through the liver, so people with kidney disease often tolerate it better than other drugs that get filtered through the kidneys.
Public health experts and organizations keep reminding everyone about the risk of antibiotic resistance. I’ve learned through my own medical care and reading research that sticking closely to a doctor’s instructions, not skipping doses, and finishing the full course all help keep these drugs working. Too many people quit early once they feel better, giving bacteria a chance to bounce back stronger. Spreading the word in clinics, schools, and pharmacies makes a difference in keeping medications like Erythromycin Ethylsuccinate useful for future generations.
Many households stock antibiotics "just in case." In practice, using Erythromycin Ethylsuccinate the right way lines up with the best approach for public health and individual care. With new bacterial threats always emerging and classic ones adapting, getting the full story straight from experienced clinicians, evidence, and real-world results helps people make good choices about managing bacterial infections—one prescription at a time.
Erythromycin Ethylsuccinate comes up often when doctors need to treat common infections. It’s been around for decades. The drug knocks out bacteria like those causing strep throat, sinus infections, or bronchitis. But like most things that fight off illness, it can bring a few problems along with the benefits.
A lot of people run into stomach trouble while using this medication. Upset stomach, nausea, even diarrhea often show up. The reason is simple: erythromycin irritates the gut lining. It sometimes knocks out good bacteria, which throws off digestion. Some folks get cramps, others burp or lose their appetite. I’ve talked to patients who had to take their pills with food to keep queasiness in check, even if the label said otherwise.
The drug can mess with the liver. Yellowing of the skin or eyes can signal something’s wrong. Doctors recognize this as jaundice, usually from liver inflammation. Trouble with the liver can crop up quickly or sneak in over a few days. People with preexisting liver issues should check in with their healthcare provider before starting a new prescription.
Antibiotics like erythromycin sometimes trigger allergic reactions. Rashes pop up, and itching or swelling follows. In rare cases, breathing gets hard or swallowing becomes tough. If that happens, there’s no waiting—one trip to the ER could prevent real danger. Allergy history should stay part of any conversation with the prescribing doctor.
Women and children deal with side effects a bit differently. Diarrhea can spark severe dehydration, especially in children. Missed school days or doctor visits usually follow.
Some data links erythromycin to irregular heartbeats. The drug lengthens the QT interval, which changes the heart’s electrical rhythm. For most people, this never matters. For someone already taking heart medicine or struggling with other health problems—think older adults or people with kidney trouble—the risk goes up. One study published in the New England Journal of Medicine found that higher doses pushed up the odds of sudden heart issues in people taking certain other drugs.
Overusing antibiotics creates another challenge: resistance. Bacteria outsmart the drug, infections last longer, and treatment choices start to shrink. By finishing the full course (even if symptoms vanish), people help slow the spread of resistant bugs. More folks need to hear that message from pharmacists and doctors.
Talking to a healthcare provider should happen before mixing erythromycin with new prescriptions or substances like grapefruit juice. Grapefruit makes side effects more likely by changing the way the body handles the drug.
Routine bloodwork can spot liver or kidney trouble before it turns serious. If common side effects get bad, switching to another antibiotic makes more sense than powering through misery. By understanding red flag symptoms and the risks unique to their own bodies, people can protect themselves better during treatment.
Erythromycin Ethylsuccinate makes a difference for a lot of people by treating bacterial infections. Doctors trust this antibiotic for things like strep throat, some kinds of pneumonia, bronchitis, or skin problems. It stands out as a real helper when penicillin can’t do the job, maybe because of allergies. I remember my own brush with bronchitis one winter, and erythromycin cleared things up when nothing else did. It’s tough on bacteria, but it can be tough on your stomach, too, which makes knowing how to take it all the more important.
Every prescription bottle lists the right dose, but turning that label into real-world action sometimes gets tricky. Some people feel tempted to double up after missing a dose or take it with a glass of juice. That’s not what works best. Erythromycin Ethylsuccinate should go down with a full glass of water, and it’s kinder on your gut if you take it with food. Citrus juice or milk makes things complicated because it messes with how your body absorbs the medicine. Checking the label and asking a pharmacist has kept me out of trouble more than once.
Bacterial infections don’t just vanish once you feel better, and cutting the prescription short invites them to come right back. Skipping doses or stopping early spreads the risk of antibiotic resistance. I’ve talked with friends who stopped their pills a few days early and landed back at the doctor’s office, feeling worse than before. Always finish the course, whether you’re feeling top-notch or just okay. Timers and phone reminders kept me on track, especially when life felt extra busy.
Doctors choose Erythromycin Ethylsuccinate for a reason. It can interact with other drugs, so it matters to keep your medication list straight. Blood thinners, statins, and certain seizure medications all clash with erythromycin. About 1 in 10 people experience side effects like nausea, cramps, or diarrhea. Serious allergic reactions stay rare, but any trouble breathing or swelling calls for a trip to the emergency room. The U.S. Centers for Disease Control and Prevention outlines ways antibiotics can help us, stressing that these medicines lose power if not used responsibly.
Anyone who struggles to swallow pills can talk with their doctor about a liquid version. If the stomach feels upset, sticking close to bland foods might ease the ride. Some pharmacies offer blister packs as reminders for those handling a lot of pills. Communication saves headaches down the road—your doctor needs to know about pregnancy, liver troubles, or other health complications before starting this medication.
Erythromycin Ethylsuccinate has carved out its place in the world of antibiotics by getting tough jobs done when others fall short. Taking it as directed means listening to the body, paying attention to the doctor’s plan, and respecting the instructions on food and timing. We all play a role in keeping antibiotics working well for everyone by not skipping, sharing, or saving doses. A little care today adds up to a lot of good down the line.
Finding out you need antibiotics can cause stress, but pregnancy or breastfeeding adds extra layers of concern. Doctors tend to prescribe antibiotics only when they feel it’s truly needed, weighing how a drug might affect both the parent and the baby. One common antibiotic, Erythromycin Ethylsuccinate, often comes up in discussions about safe options for those who are expecting or nursing. The stakes feel high because nobody wants to take chances with an unborn or newborn child.
Doctors have prescribed erythromycin for decades. This particular form, Erythromycin Ethylsuccinate, usually treats infections in the skin, throat, chest, or urinary tract. It stands out because penicillin allergies aren’t rare, and erythromycin steps in as an alternative. The risks associated with untreated bacterial infections run higher than the risks tied to erythromycin in many situations. Untreated infections could harm both the parent and the baby, causing preterm birth or, in severe cases, more serious complications.
Looking for reassurance about any drug use during pregnancy is natural. Erythromycin sits in FDA Pregnancy Category B. That means animal studies haven’t shown a risk to the fetus, and there isn't any controlled data in pregnant people that point to problems. Decades of careful use back up this classification, without strong links to birth defects or miscarriage found so far.
Some older studies linked erythromycin to a slight increase in risk of a rare infant condition called pyloric stenosis. More recent reviews cast doubt on the strength of this connection, especially when erythromycin is given for short periods and only as needed. Numerous obstetricians have told their patients, “If you really need an antibiotic, this one’s among the safest bets.” Still, it’s always smart to have a clear conversation with your healthcare provider. Every person’s risk factors look a little different, and timing during pregnancy matters.
For parents nursing a newborn, the question shifts to what crosses into breast milk. Erythromycin does pass into breast milk in small amounts. Babies might experience a little stomach upset or mild diarrhea, which lines up with what happens if they take erythromycin directly. Again, the pyloric stenosis story comes up, though breastfed infants receive far less drug than those on a full dose.
Pediatricians tend to reassure patients that erythromycin can be used if needed. If a doctor recommends it, they usually watch out for signs of tummy discomfort or severe vomiting in the baby. Based on years of experience, medical teams recognize that addressing infections can far outweigh the small risks posed by the trace amounts entering breast milk.
All medications should run through a doctor or midwife when pregnancy or breastfeeding enters the picture. Trust between a patient and their medical team makes a big difference. Medical teams often suggest finishing the full course if an antibiotic is truly needed, rather than stopping early. That way, the infection clears without giving bacteria a chance to grow stronger.
For anyone anxious about medication, it helps to stay in touch with a healthcare team while watching for any changes in how you or your baby feels. Sick parents can’t help their little ones if they aren’t well themselves. Erythromycin Ethylsuccinate has stood up well to long-term scrutiny. A careful, case-by-case approach, checked by a trusted professional, keeps both parent and child as safe as possible.
Sorting out drug interactions has always meant protecting real people from side effects or complications that can change lives. Erythromycin Ethylsuccinate, a widely used antibiotic, doesn’t work in a vacuum. Every medicine I’ve taken or prescribed brings its own crowd along—other drugs, supplements, or over-the-counter remedies. Sometimes even food plays a role in what comes next. Missing a key interaction can turn a solution into a problem, and I’ve seen it enough to learn not to gamble with it.
Mixing Erythromycin Ethylsuccinate with certain medications can raise the risk of serious side effects. For example, pairing it with statins (like simvastatin or lovastatin) often leads to muscle pain or, in rare cases, something as dangerous as rhabdomyolysis. Using this antibiotic with drugs designed to control heart rhythm, such as amiodarone or quinidine, in some cases can trigger irregular or dangerous heartbeats. This happens because erythromycin slows the breakdown of these medicines in the liver, so levels rise higher than intended.
Some drugs used for mood or psychiatric needs—like pimozide—get tangled up with erythromycin in a way that can make heart rhythm problems almost certain. Antacids, on the other hand, can throw a wrench into how the body absorbs erythromycin, so the antibiotic never quite hits its stride. Each of these combinations isn’t just a medical statistic on a page—I’ve listened to people describe the strange way their pulse changed or the muscle cramps that left them scared. Health is personal, and so are the ways medicines mix or clash inside us.
Most antibiotics find their way through the body relying on the liver’s detox assembly line. Erythromycin Ethylsuccinate’s journey slows if the body is already working on other drugs that use the same path or if something is blocking the enzyme CYP3A4. Grapefruit juice—which gets mentioned almost as often as the drug itself—blocks this enzyme, leading to higher levels in the bloodstream and an increased likelihood of side effects. Letter-of-the-law labels and package inserts mention this, but seeing a person walk through the ER with a spun-out heart rate after mixing a few innocent medications makes it stick in the mind.
Checking drug interactions has no shortcut. Pharmacists regularly stand as a last line of defense; they can catch issues a stressed patient or even a busy doctor might miss. Electronic health records flag dangerous pairs, but real conversations make the biggest impact. Patients who list every supplement and energy drink help build that safety net even stronger. Looking at the full medication list, asking direct questions, and encouraging people to check before switching brands or starting new prescriptions all matter.
Education never stops, either for professionals or the public. Encouraging patients to check with their pharmacist before grabbing something new from the drugstore shelf gives another layer of protection. Stories of unfortunate drug interactions serve as learning tools, not scare tactics. One person’s experience can help twenty others avoid the same outcome. That’s the backbone of patient care—sharing what’s known, admitting what isn’t, and doing what’s possible to keep people safe.
| Names | |
| Preferred IUPAC name | Erythromycin 6-O,6′-diethylsuccinate |
| Other names |
Erythrocin Stearate E.E.S. Ethylsuccinate erythromycin ERYC Eryped |
| Pronunciation | /ɪˌrɪθ.rəˈmaɪ.sɪn ˌiː.θɪl.səkˈsɪn.eɪt/ |
| Identifiers | |
| CAS Number | 1264-62-6 |
| 3D model (JSmol) | `/ModelViewerApplet/em?code=erythromycin%20ethylsuccinate` |
| Beilstein Reference | 1733976 |
| ChEBI | CHEBI:4917 |
| ChEMBL | CHEMBL16234 |
| ChemSpider | 126473 |
| DrugBank | DB00109 |
| ECHA InfoCard | ECHA InfoCard: 100.043.276 |
| EC Number | 3.1.1.8 |
| Gmelin Reference | Gmelin Reference: 83249 |
| KEGG | C07618 |
| MeSH | D004947 |
| PubChem CID | 656656 |
| RTECS number | QJ8585000 |
| UNII | 95X39EMR0W |
| UN number | UN3077 |
| CompTox Dashboard (EPA) | DTXSID3023506 |
| Properties | |
| Chemical formula | C43H75NO16 |
| Molar mass | 862.06 g/mol |
| Appearance | White or almost white crystalline powder |
| Odor | Odorless |
| Density | Density: 1.1 g/cm3 |
| Solubility in water | Slightly soluble in water |
| log P | 0.74 |
| Acidity (pKa) | 12.13 |
| Basicity (pKb) | 8.88 |
| Magnetic susceptibility (χ) | \-77.5 × 10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.545 |
| Viscosity | Viscous liquid |
| Dipole moment | 3.73 D |
| Pharmacology | |
| ATC code | J01FA02 |
| Hazards | |
| Main hazards | May cause allergic reactions, gastrointestinal disturbances, liver dysfunction, and potential cardiac effects such as QT prolongation. |
| GHS labelling | GHS07, GHS08 |
| Pictograms | lactose-free, gluten-free, prescription-only |
| Signal word | No Signal Word |
| Hazard statements | H302: Harmful if swallowed. H315: Causes skin irritation. H319: Causes serious eye irritation. H335: May cause respiratory irritation. |
| Precautionary statements | Keep out of reach of children. Use only as directed by your doctor. Avoid contact with eyes. Consult your doctor if symptoms persist or worsen. Store in a cool, dry place away from direct sunlight. |
| NFPA 704 (fire diamond) | NFPA 704: 2-1-0 |
| Flash point | > 180°C |
| Autoignition temperature | 360°C |
| Lethal dose or concentration | LD50 oral rat 5,000 mg/kg |
| LD50 (median dose) | LD50 (median dose): Mouse oral LD50 = 16,000 mg/kg |
| NIOSH | ANW8GC22XP |
| PEL (Permissible) | PEL (Permissible Exposure Limit) for Erythromycin Ethylsuccinate: Not established |
| REL (Recommended) | 400 mg every 6 hours |
| IDLH (Immediate danger) | Not listed |
| Related compounds | |
| Related compounds |
Erythromycin Erythromycin estolate Erythromycin stearate Erythromycin lactobionate Erythromycin gluceptate Clarithromycin Azithromycin Roxithromycin |
